Johnson & Johnson JNJ

IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?

The Motley Fool · 2h ago

Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF

The Motley Fool · 2d ago

Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity

Investing.com · 2d ago

Is Johnson & Johnson a Buy After Its Latest Earnings Report?

The Motley Fool · 2d ago

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. · 3d ago

Nasdaq Forecast: NDX Extends Gains After Cooler PPI

Investing.com · 3d ago

Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight

GlobeNewswire Inc. · 5d ago

Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors.

The Motley Fool · 6d ago

1 Top Vanguard ETF to Buy Before the Next Market Crash

The Motley Fool · 6d ago

History Says Doing This 1 Thing Will Score You an Investing Win -- Even After a Market Crash.

The Motley Fool · 7d ago

Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGR

GlobeNewswire Inc. · 8d ago

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

The Motley Fool · 9d ago

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

The Motley Fool · 10d ago

This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026

The Motley Fool · 10d ago

BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?

The Motley Fool · 10d ago

2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now

The Motley Fool · 11d ago

3 Stocks to Buy and Hold: The Long-Term Play for Your Portfolio

The Motley Fool · 12d ago

3 Dividend ETF Picks That Could Build Serious Long-Term Wealth

The Motley Fool · 13d ago

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?

The Motley Fool · 13d ago

Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.

The Motley Fool · 14d ago

Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

The Motley Fool · 15d ago

[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire Inc. · 15d ago

UnitedHealth is Near its 52-Week High. Wall Street Is Starting to Notice This Blue Chip Stock -- and So Should You.

The Motley Fool · 22d ago

Nasdaq Selloff Shows AI Leadership Is Turning Into Market Drag

Investing.com · 22d ago

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

The Motley Fool · 22d ago